Cargando…

The evolving role of radiotherapy in non-small cell lung cancer

Lung cancer is the most commonly diagnosed cancer and biggest cause of cancer mortality worldwide with non-small cell lung cancer (NSCLC) accounting for most cases. Radiotherapy (RT) plays a key role in its management and is used at least once in over half of patients in both curative and palliative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Sean, Banfill, Kathryn, Aznar, Marianne C., Whitehurst, Philip, Faivre Finn, Corinne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913359/ https://www.ncbi.nlm.nih.gov/pubmed/31535580 http://dx.doi.org/10.1259/bjr.20190524

Ejemplares similares

Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2022)

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer
por: Fornacon-Wood, Isabella, et al.
Publicado: (2022)

Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
por: Banfill, Kathryn, et al.
Publicado: (2021)

Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
por: Banfill, Kathryn, et al.
Publicado: (2022)

Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
por: Levy, Antonin, et al.
Publicado: (2020)

Thoracic radiotherapy in small cell lung cancer—a narrative review
por: Levy, Antonin, et al.
Publicado: (2021)

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
por: Haslett, Kate, et al.
Publicado: (2016)

A novel use for routine CBCT imaging during radiotherapy to detect COVID-19
por: Clough, A., et al.
Publicado: (2022)

Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy
por: Johnson-Hart, Corinne, et al.
Publicado: (2020)

Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy
por: Davey, Angela, et al.
Publicado: (2021)

Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer
por: Crockett, Cathryn B., et al.
Publicado: (2021)

Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)
por: Banfill, Kathryn Banfill, et al.
Publicado: (2021)

Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice
por: Haslett, Kate, et al.
Publicado: (2018)

P09.17 Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer
por: Haslett, K., et al.
Publicado: (2021)

The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer
por: Perdrizet, Kirstin, et al.
Publicado: (2021)

A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
por: Zhou, Yue, et al.
Publicado: (2020)

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
por: Sabari, Joshua K, et al.
Publicado: (2017)

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
por: Conibear, John, et al.
Publicado: (2018)

Early reduction in tumour [(18)F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone
por: Trigonis, Ioannis, et al.
Publicado: (2014)

Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value
por: Walker, Michael J., et al.
Publicado: (2015)

Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
por: McWilliam, Alan, et al.
Publicado: (2020)

Role of Radiotherapy in Metastatic Non-Small Cell Lung Cancer
por: Faria, Sergio L.
Publicado: (2014)

Resectable non-small cell lung cancer: an evolving landscape
por: Loh, Jerold, et al.
Publicado: (2022)

203MO Changes in management for patients with lung cancer treated with radical radiotherapy during the first wave of the COVID-19 pandemic in the UK (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
por: Mulvenna, Paula, et al.
Publicado: (2016)

PO-1198 Changes in radical radiotherapy for lung cancer patients in the UK during the COVID-19 pandemic.
por: croxford, W., et al.
Publicado: (2021)

Automated gross tumor volume contour generation for large‐scale analysis of early‐stage lung cancer patients planned with 4D‐CT
por: Davey, Angela, et al.
Publicado: (2020)

CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer
por: Walls, Gerard M., et al.
Publicado: (2020)

Predicting cancer relapse following lung stereotactic radiotherapy: an external validation study using real-world evidence
por: Davey, Angela, et al.
Publicado: (2023)

Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer
por: Péchoux, Cecile Le, et al.
Publicado: (2013)

Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer—A Review
por: Süveg, Krisztian, et al.
Publicado: (2022)

The evolving roles and controversies of radiotherapy in the treatment of glioblastoma
por: Hau, Eric, et al.
Publicado: (2016)

Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung Cancer
por: Baudoux, Nathalie, et al.
Publicado: (2023)

Precision radiotherapy for non-small cell lung cancer
por: Yang, Wen-Chi, et al.
Publicado: (2020)

The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer
por: Nosaki, Kaname, et al.
Publicado: (2015)

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010–2015
por: Aznar, Marianne C., et al.
Publicado: (2018)

Role of prognostic nutritional index in postoperative radiotherapy for non‐small cell lung cancer
por: Ryu, Hyejo, et al.
Publicado: (2023)

Role of the cGAS-STING pathway in radiotherapy for non-small cell lung cancer
por: Yang, Chunsheng, et al.
Publicado: (2023)

Association between radiotherapy protocol variations and outcome in the CONVERT trial
por: Mir, Romaana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ie43nfellj9r5kj75dbt3sqk82